. Author manuscript; available in PMC: 2016 Nov 1.

Published in final edited form as: Am J Surg Pathol. 2015 Nov;39(11):1548–1557. doi: 10.1097/PAS.0000000000000476

Table 4.

Summary of molecular histotype results for 22 cases of mixed epithelial ovarian cancer.

Histotypes based on morphological review^*	Pure histotype based on molecular studies (# of cases)	Type of pure EOC	Mixed based on molecular studies (# of cases)	Histotypes in mixed EOC by molecular studies
EC/CCC (n=9)	3	CCC (n=2)	6	EC/CCC (n=6)
EC/CCC (n=9)	3	EC(n=1)	6	EC/CCC (n=6)
EC/LGSC/SBT (n=4)	2	HGSC(n=1)	2	EC/CCC (n=1)
EC/LGSC/SBT (n=4)	2	EC(n=1)	2	EC/LGSC (n=1)
HGSC/CC (n=3)	1	HGSC (n=1)	2	HGSC/CCC (n=2)
CCC/MC (n=2)	1	CCC (n=1)	1	CCC/MC (n=1)
MC/SBT (n=1)	1	EC(n=1)	0	-
CCC/SMBT/EC (n=1)	1	EC (n=1)	0	-
MC/Brenner BT (n=1)	0	-	1	CCC/MC (n=1)
MC/HGSC (n=1)	0	-	1	MC/HGSC (n=1)
Total: 22 cases	Total: 9 (41%)		Total mixed based on molecular studies: 13 (59%)	Morphology concordant with molecular results in 11/13 mixed cases (85%)

SMBT: seromucinous tumor; Brenner BT: brenner borderline tumor